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Abstract 
The advent of highly active antiretroviral therapy (HAART) regimens has resulted in 
significantly reduced morbidity and mortality due to HIV infection. However, in spite of 
more effective treatment options, for some individuals, HIV infection continues to be 
associated with clinically significant cognitive impairment, particularly in the later stages 
of disease. The purpose of the present study was to examine the usefulness of the anti-
saccade task as a measure of cognitive impairment in a community sample of older HIV+ 
adults. Using an archival data set, this exploratory study examined how performance on 
the anti-saccade task related to the diagnosis of HIV-associated neurocognitive disorders. 
Specifically, the study focused on HIV-associated mild neurocognitive disorder (MND) 
and HIV-associated dementia (HAD). The presence of MND or HAD was diagnosed 
using participants’ neuropsychological test performance and self-reported functional 
status. It was hypothesized that deficits in anti-saccade task performance would be 
associated with deficits on other measures of cognitive functioning and with diagnosis of 
HAD. There were 81 HIV+ adults in the sample. They had a mean age of 48.35 years and 
reported an average of just over 13 years of education. The HIV+ participants were 
predominantly male (69%) and African American (57%), with significant numbers of 
Caucasian (30%) and Hispanic (14%) persons as well. Overall, the HIV+ participants in 
this sample reported little functional impairment in their daily lives, performed relatively 
well on the neurocognitive measures, and showed little difficulty with the anti-saccade 
task. In general, the sample appeared relatively healthy, perhaps reflecting the improved 
treatments for HIV in recent years. The lack of variance on cognitive measures, including 
the anti-saccade task, made it difficult to test the study’s hypotheses. Exploratory 
analyses showed modest but statistically significant correlations between anti-saccade 
xvi 
task performance and WAIS-R Digit Symbol scores. Considering both anti-saccade error 
rates and task scores, poorer performance was associated with lower scores on Digit 
Symbol. Other findings, limitations of the study, and suggestions for future research are 
discussed.    
 
 
1 
Introduction 
Clinical and scientific attention to cognitive and functional status among HIV-1 
diagnosed individuals has grown significantly in recent years, as has the need for such 
findings.  From 2004 through 2007, the estimated number of newly diagnosed HIV/AIDS 
cases in the 34 states of the U.S. with confidential name-based HIV infection reporting 
increased by 15% (CDC, 2007).  HIV infection is the most common preventable and 
treatable cause of neurocognitive impairment in individuals under age 50 years (Ances & 
Ellis, 2007).  HIV-1 is the form of the virus that causes disease in most of the world, 
including the United States, Europe, Asia, Latin America, and most of Africa, while HIV-
2 is predominantly clustered in West Africa (CDC, 1998).  Throughout this research, the 
term “HIV” refers to HIV-1 and this type of infection will be the sole focus of study.     
The U.S. Centers for Disease Control and Prevention (CDC, 1992) assesses the 
clinical severity of HIV disease by the presence of specific HIV-related conditions.  
Clinical categories denoted by letters A, B, or C provide a classification system based on 
symptoms to identify disease stage.  Clinical category “A” signifies asymptomatic 
conditions.  Clinical Category “B” is defined by symptomatic conditions (a) attributed to 
HIV infection or (b) indicated by a defect in cell-mediated immunity and considered to 
have a clinical course or management that is complicated by HIV infection.  Clinical 
Category “C” is identified by the presence of “AIDS-indicator” conditions, those that 
signal HIV infection that has progressed to a diagnosis of AIDS.   
The American Psychiatric Association (Forstein et al., 2006) lists four central 
nervous system manifestations of direct HIV infection by disease stage, including (a) 
acute infection, (b) asymptomatic infection, (c) early symptomatic infection, and (d) late 
symptomatic infection.  According to the APA (2000), prior to the introduction of highly 
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active antiretroviral therapy (HAART), in the asymptomatic stage there was a 20-30% 
prevalence of significant cognitive-motor impairment, while in early symptomatic 
infection, significant impairment occurred in up to 50% of patients. In late symptomatic 
infection (AIDS), impairment occurred in anywhere from 60 to 90% of patients.  The 
advent of HAART regimens such as protease inhibitors, nucleoside analogue reverse 
transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors has resulted in 
decreased plasma viral load to levels as low as non-detectable, allowing for a 
significantly reduced morbidity and mortality due to HIV infection (APA, 2000). 
Moreover, since the introduction of HAART, research has shown a reduction in the 
prevalence of cognitive impairment among persons with HIV (APA, 2000), with levels of 
such impairment dropping to as low as 5% in the asymptomatic stage, 15% in early 
symptomatic infection, and 25% in late symptomatic infection among treated persons.  
Due to medical advances, namely HAART, many HIV+ individuals in industrialized 
countries now live upwards of 20 years after initial infection, even long after they have 
developed AIDS (World Health Organization, 2004).  However, some studies suggest 
that neurocognitive impairment progresses despite use of HAART (Power, McArthur, & 
Johnson, 1994), and ultimately, the prevalence of clinically relevant impairment 
statistically increases with stage of disease. In summary, many new cases arise every day, 
and diagnosed patients are living longer, higher quality lives.  However, in spite of 
effective treatment options, for some individuals, HIV infection continues to be 
associated with clinically significant cognitive impairment, which may in turn be 
associated with parallel declines in functional status.    
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The HIV Neurobehavioral Research Center (HNRC) at the University of 
California, San Diego (UCSD) (Cherner et al., 2007) has established three categories or 
levels of impairment for HIV-related neurocognitive complications including (a) 
Asymptomatic neurocognitive impairment (ANI), (b) HIV-associated mild 
neurocognitive disorder (MND), and  (c) HIV-associated dementia (HAD).   Collectively, 
these disorders are referred to as HIV-associated neurocognitive disorders, or HAND 
(Antinori et al., 2007).  The two symptomatic diagnostic categories, MND and HAD, 
were the focus of the present research.   
HNRC (2007) defines MND by multiple features including (a) acquired mild-to-
moderate impairment in cognitive function documented by a score of at least one 
standard deviation below demographically-corrected norms on neuropsychological tests 
of at least two different cognitive domains; (b) cognitive impairment which interferes, at 
least mildly, with daily functioning; and (c) functional impairment that has been observed 
for ≥1 month.  Additional exclusionary criteria require that (a) the impairment does not 
meet criteria for delirium or dementia, and (b) the impairment is not fully explained by 
comorbid conditions.   
Diagnosis of HIV-associated dementia (HAD) according to HNRC’s 2007 criteria 
requires: (a) acquired moderate-to-severe cognitive impairment documented by a score of 
at least 2 SD below demographically corrected normative means in at least two different 
cognitive areas, and (b) marked difficulty in activities of daily living due to the cognitive 
impairment.  Additionally, the impairment should have been present for at least one 
month or more, not meet criteria for delirium or dementia, and not be adequately 
explained by comorbid conditions.  Proper diagnosis of these conditions is extremely 
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important not only for treatment of the associated symptoms, but also in order to 
anticipate potential secondary effects of deficits such as lapses in medication compliance 
and appointment keeping.   
The standards of the American Psychiatric Association’s (2005) Office of HIV 
Psychiatry recommend the following components be included in a comprehensive 
evaluation of the HIV+ patient: (a) a general medical work-up; (b) a psychiatric work-up; 
(c) a cognitive screening work-up; and (d) a functional status assessment.  Because both 
HAD and MND are diagnoses of exclusion, it is essential that any comprehensive 
evaluation rule out other etiologies of cognitive-motor impairment, and attention to rule-
out diagnoses and etiologies for deficits should be of primary focus.  Furthermore, since 
neuropsychiatric symptoms may improve with treatment and may wax and wane over 
time, serial monitoring is recommended. 
One popular option for brief assessment, the Mini Mental Status Exam (MMSE) 
(Folstein, 1975; Pessin, Rosenfeld, Burton, & Breitbart, 2003) has been utilized despite 
the fact that it was originally validated for identifying Alzheimer’s dementia and has 
many items that are representative of cortical functions.  More recent research has 
demonstrated that neurocognitive decline is not readily detected by the MMSE unless the 
patient is severely demented (Skinner, Adewale, DeBlock, Gill, & Power, 2009). The 
MMSE may not be an ideal measure for the detection of cognitive deficits typically 
associated with HIV because many of the items on the evaluation map cortical 
dysfunction rather than subcortical cognitive changes.  Since MND and HAD are both 
primarily subcortical processes, the MMSE may have limited sensitivity to identifying 
these disorders.   
5 
Several brief neuropsychological tests have been developed specifically for 
clinical use with an HIV+ population, including the HIV Dementia Scale (HDS) (Power, 
Selnes, Grim, & McArthur, 1995) and a derivative form, called the International HIV 
Dementia Scale (IHDS) (Sacktor, Wong, & Nakasujja, 2005); the Mental Alteration Test 
(Jones, Teng, Folstein, & Harrison, 1993); the Executive Interview (Berghuis, Uldall, & 
Lalonde, 1999); and the HIV Dementia Assessment (Grassi, Perin, Borella, & Mangoni, 
1999).  A popular measure in relatively wide use in clinical and research settings (Chang, 
Ernst, Leonido-Yee, & Speck, 2000; Chang et al., 1999), the HIV Dementia Scale 
(Power, Selnes, Grim, & McArthur, 1995) is comprised of four tasks: the anti-saccade 
task, a timed written alphabet measure, verbal word list memory recall, and written copy 
of a cube.  The cutoff score for suspected HAD is ten (or less) of 16 in the sum total of all 
four tasks.  The total score can also be pro-rated to exclude the anti-saccade task with a 
revised cut off score of less than 7.5 out of 12 (Davis, Skoloasky, Selnes, Burgess, & 
McArthur, 2002).  While the HIV Dementia Scale is widely used, the anti-saccade task 
embedded within the measure deserves closer individual attention in part due to its 
limited reliance on language, which sets it apart from other brief screening measures.  In 
particular, research is needed to determine the stand-alone clinical utility of the anti-
saccade task in assessment of HIV infected individuals.  Use of such a tool may be 
especially beneficial those who speak English as a second language who might otherwise 
be alienated by language-dependent measures.   
In many patient populations, the anti-saccade task has emerged as an important 
measure for investigating the flexible control that an individual has over his or her 
behavior.  It requires that participants must suppress the reflexive urge to look at a visual 
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target that appears suddenly in the peripheral visual field and must instead look away 
from the target in the opposite direction.  In a typical anti-saccade task, the viewer fixates 
his or her gaze on a central location, a stimulus is flashed to one side of fixation, and the 
task is to not look at the location of the cue but rather to make an anti-saccadic eye 
movement in the opposite direction from where the cue was presented. If the viewer fails 
to refrain from responding to the cue, a pro-saccadic eye movement toward the cue will 
be generated before the anti-saccade (Guitton, Buchtel, & Douglas, 1985; Hallet, 1978; 
Hallet & Adams, 1980; Roberts, Hager, & Heron,, 1994). A crucial step involved in 
performing this task is the top-down inhibition of this reflexive, automatic saccade.  
Success on this task, therefore, requires the ability to override the reflexive response of 
initiating a saccade toward a target and is tied to intact executive functions.   
In the anti-saccade task, response suppression is required to resist moving the 
eyes toward the briefly exposed target. Whereas the superior colliculus mediates reflexive 
eye movements to visual targets, that is, pro-saccades (Hikosaka & Wurtz, 1985; Schiller, 
Sandell, & Maunsell, 1987), the frontal eye fields and dorsolateral prefrontal regions 
support the suppression of reflexive eye movement behavior, thereby enabling saccades 
in the opposite direction from the target, that is, anti-saccades (Guitton et al., 1985; 
O’Driscoll et al., 1995).  Patients diagnosed with various neurological and/or psychiatric 
disorders that affect the frontal lobes or basal ganglia find it difficult to suppress the 
automatic pro-saccade, revealing a deficit in top-down inhibition (Munoz & Everling, 
2004).  Performance has also been shown to change with cognitive demands. For 
example, increasing working memory demands by adding an arithmetic task produces 
slower and less accurate performance (Roberts et al., 1994), suggesting a role of 
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executive functioning in this task.  The neurocognitive areas utilized in the execution of 
this task make it a promising option as a screening measure for cognitive decline.   
There are several populations for which the anti-saccade task has been 
demonstrated to be useful in examining cognition.  Because of the dependency on frontal 
and basal ganglia structures, the anti-saccade task has emerged as an important clinical 
tool for investigating development and dysfunction in various neurological and 
psychiatric disorders (Leigh & Kennard, 2003; Everling & Fischer, 1998).  Many patient 
groups have been studied using the anti-saccade task and key findings have been 
interpreted in the context of established neurophysiological findings to make specific 
predictions about how pathophysiology can influence top-down inhibitory control of 
saccade neurons and accumulation of activity toward the saccadic threshold (Munoz & 
Everling, 2004).  A number of studies have shown that patients with schizophrenia 
perform poorly on anti-saccade tasks, with two common findings being increased error 
rates and prolonged reaction times for correct anti-saccades (Broerse, Crawford, & den 
Boer, 2001).  Both adults and children diagnosed with ADHD have distinct difficulties in 
suppressing the automatic pro-saccade on anti-saccade trials (Munoz, Armstrong, 
Hampton, & Moore, 2003).  Interestingly, among this population, there is no change in 
the mean reaction time of correct anti-saccades despite the increase in direction errors, 
implying that there is no deficit in the ability to initiate a voluntary response.  Reaction 
times for correct anti-saccades are significantly increased in patients with Parkinson’s 
Disease (Chen, Chen, & Tsai, 1999; Briand, Strallow, Hening, Poizner, & Sereno, 1999) 
indicating that the activity required to trigger correct anti-saccades might accumulate 
more slowly in these patients. This effect is not surprising since one of the hallmarks of 
8 
Parkinson’s disease is a decreased ability to generate voluntary responses (Lezak, 2005).  
While the research findings and clinical implications for these populations may be 
dissimilar from those of the cognitively impaired HIV+ individual, consideration of 
previous research findings demonstrates that the anti-saccade task may be a suitable test 
of inhibitory control and the ability to generate voluntary actions.  It therefore appears 
promising as an avenue for further study with alternate populations, including HIV+ 
individuals. 
Two research questions were examined as part of the current study.  First, how do 
HIV+ individuals perform on the anti-saccade task?  Second, how does performance on 
the anti-saccade task relate to cognitive impairment and diagnoses of MND and HAD 
among HIV+ men and women?  This study provided an opportunity to explore the 
sensitivity and specificity of the anti-saccade task as a measure of MND and HAD among 
HIV+ individuals.   It was hypothesized that severe deficits in anti-saccade task 
performance would be associated with performance deficits on other measures of 
cognitive functioning.  It was also hypothesized that deficits in anti-saccade performance 
would be associated with diagnosis of HAD among HIV+ individuals.  
If significant associations were found between anti-saccade task performance and 
related diagnoses of cognitive impairment, then routine implementation of the anti-
saccade task as a screener for cognitive complications in HIV+ individuals could be a 
time- and cost-effective strategy for the identification of potential neuropsychological 
decline in a primary care environment.  Because the anti-saccade task is a less-language 
dependent measure than many screening measures commonly used (e.g., memory recall 
exercises, spontaneous list generation, or self-report measures), it may show promise for 
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clinics in communities where English is commonly a second language among patients 
seeking care.  This could provide health professionals with a useful indicator of when a 
referral for further neuropsychological screening and assessment might be appropriate.  
Benefits of proper screening by the medical community potentially include (a) 
identifying patients who may benefit from further neuropsychological testing and/or 
neurological referral, (b) identifying deficiencies that might influence treatment 
compliance, and (c) improving accuracy in the prediction of prognosis.     
Method 
Research Context and Design 
The data set used in this study was derived from a longitudinal study that 
attempted to determine the extent to which aging affects the presentation of progression 
of HIV-1 infection in terms of neuropsychological (NP) test performance and 
impairment, HIV-1-associated cognitive-motor disorders, functional status in activities of 
daily living, immunologic measures, and virologic measures.   The original study was 
proposed as a two by two design comprised by (a) age category with two levels: younger 
(ages 18 to 39) and older (age ≥ 50); and (b) HIV serostatus with two levels: HIV+ and 
HIV-.  The research was initially conducted at the University of Miami in Miami, FL 
with Karl Goodkin, M.D., Ph.D. as principal investigator, and later continued at Cedars-
Sinai Medical Center in Los Angeles, California.  Permission to utilize the archival data 
set was granted in writing from Dr. Goodkin and from Enrique Lopez, Psy.D., Senior 
Clinical Research Neuropsychologist at Cedars-Sinai.  The present study utilized 
participant data collected both at the University of Miami and at Cedars-Sinai Medical 
Center. Data used in the present research was collected between December 1999 and 
August 2009.  Participants were compensated $200 for their first year of participation in 
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the parent study (all derived data for current research was sourced from first year visits), 
with the potential for a total of $630 in total compensation over the course of three years.   
The present study included both exploratory and correlational research design 
elements.  The overall purpose was to explore the extent to which performance on the 
anti-saccade task was associated with relevant diagnoses of cognitive decline among 
HIV+ individuals.  In addition, the researcher examined the extent to which 
determination of cognitive impairment by means of the anti-saccade task alone 
corresponded to the determination of cognitive impairment by more traditional means 
(i.e., through the use of multiple neuropsychological measures and functional assessment 
data).  Because this was an archival study, the researcher did not have the ability to 
modify the research procedures or collect additional data. 
Procedure 
In the current research study, a three-step process was planned to determine if 
performance on the anti-saccade task was in fact associated with cognitive decline in 
HIV-infected individuals.  Initially, participants from the original study who met criteria 
for assignment to the MND or HAD groups were identified, based on their performance 
on neuropsychological and functional measures.  Next, study participants were assigned 
to MND or HAD groups solely on the basis of the number of errors on the anti-saccade 
task (i.e., independent of performance on other neuropsychological or functional 
measures).  Finally, to determine the predictive value of the anti-saccade task, the 
concordance between these two methods for assigning HIV+ individuals to MND and 
HAD groups was examined.  The researcher obtained approval from Pepperdine 
University’s Graduate and Professional Schools Institutional Review Board prior to 
beginning any work with the archival data set.  As will be described in greater depth and 
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presented with results and discussion of data, the initial step of assigning participants to 
the MND or HAD groups proved problematic due to the relatively low numbers of 
persons with severe impairment and the lack of concordance between neuropsychological 
and functional measures.  Therefore, it was necessary to adjust how the initial 
classifications were made, in order to respond to challenges encountered with the archival 
data set.   
Participants 
Through August 2009, a total of 279 participants had completed assessments, met 
inclusionary/exclusionary criteria, and been entered into the parent study database.  Of 
these, a total of 119 patient records had recorded anti-saccade task scores and error rates 
necessary for inclusion in the present study.  A further review of completeness of 
neuropsychological and functional status data was also necessary with the potential for 
participants to be eliminated based on absence of critical data, and an additional five 
participants were eliminated based on missing critical data in their neuropsychological 
testing batteries.   A final number of 114 participants possessed sufficient data in anti-
saccade, functional, and neuropsychological measures to be included in the final analysis.  
For patient records in which data was available for both baseline assessment and 
subsequent annual follow-up assessments, only the first visit in which the required 
elements of data were collected (i.e., anti-saccade task scores and cognitive/functional 
measure scores to designate diagnostic category) was included in the present study.  Of 
the 114 participants that had sufficient data to be included in the final analysis, 18 were 
missing one or more scores from their neuropsychological assessment battery, but had a 
sufficient amount of data to calculate functioning within all representative domains.  In 
these 18 cases, their HAND-related diagnoses could still be calculated according to 
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procedures described previously despite these missing scores.  The demographic 
characteristics of the participants in the present study are summarized, described, and 
presented with the research results.       
Inclusion criteria approved for men and women participating in the original study 
were as follows: (a) for those HIV+ individuals, early or late symptomatic clinical disease 
stage; (b) membership in one of two age groups- 18-39 or > 50 years of age; (c) 
willingness to provide documentation of HIV serostatus (HIV+ or HIV-) or be tested if 
serostatus was unknown; (d) willingness to participate for five years; and (e) English as 
the primary language of predominant usage.  Exclusion criteria for the original cohort 
were: (a) current, systemic, acute opportunistic infection or tumor requiring 
chemotherapy; (b) current CNS infections or tumors associated with HIV infection that 
would potentially interfere with neuropsychological testing or completion of the study 
procedures; (c) severe HAD, by AAN 1991 criteria (exclusion necessary to ensure ability 
to perform the neuropsychological test battery); (d) non-HIV associated neurological 
disease (e.g., history of epilepsy, non-correctable visual or hearing impairments, prior 
cerebrovascular accident, Alzheimer's disease at entry, or multi-infarct dementia); (e) 
history of or current major psychiatric disorder (e.g., schizophrenia, bipolar affective 
disorder, or major depressive disorder); (f) mental retardation, learning disorders, motor 
skills disorder, disruptive behavior and attention deficit disorders, and pervasive 
developmental disorder; (g) current alcohol or substance dependence or history of alcohol 
or substance abuse disorder within the past three months; (h) collagen vascular disease; 
(i) severe chronic obstructive pulmonary disease (i.e., resting hypercarbia, O2 or steroid 
dependency); (j) severe congestive heart failure (class IV); (k) unstable angina; (l) 
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myocardial infarction within prior 6 months; (m) use of systemic steroids (catabolic or 
anabolic); (n) hepatic failure; (o) renal failure; (p) immunostimulant therapies and other 
trials of non-FDA-approved ARV medications; and (q) residence outside of counties 
within and adjacent to the data collection sites. 
At the evaluation appointment of the parent study from which the present research 
was derived, information was provided to the potential subjects on the goals of the 
research, the time commitment (number of evaluations and time per evaluation), and the 
study procedures (cognitive tasks, psychosocial instruments, psychiatric interview and 
rating, history and physical examinations, blood samples, and urine toxicology screens).  
Opportunity was given to respond to any questions.  Staff then obtained the signed 
informed consent forms, written permission for HIV antibody testing, a bilateral medical 
release form with the primary care provider, and required HIPAA forms.  Each 
participant in the study submitted to a medical history and physical examination, review 
of existing medical records on bilateral release, collection of cognitive data via 
neuropsychological testing, collection of clinical laboratory measures of HIV progression 
for immunologic and virologic research purposes, ratings of functional status, and 
specimen submission to a plasma and peripheral blood mononuclear cell repository. 
Instruments 
 Anti-saccade task.  The anti-saccade task that was used in this research is a task 
embedded within the widely recognized HIV Dementia Scale, developed by Power, et al., 
(1995).  The HIV Dementia Scale (HDS) consists of four tasks including a timed written 
alphabet measure, the anti-saccade task, a verbal word list memory recall, and written 
copy of a cube.  The time taken to complete the written alphabet is converted to a 
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numerical score, with a maximum score of six.  The total number of errors in 20 trials of 
the anti-saccade task is converted into a maximum score of four.  Recall performance is 
measured with one point given for each word recalled spontaneously or one-half point for 
each word recalled with a semantic clue, for a maximum score of four.  Time taken to 
copy the cube is converted to a maximum numerical score of two.  The cutoff score for 
suspected HAD is ten (or less) of 16 in the sum total of all four tasks.  The HDS rates 
well in both reliability and validity; it has demonstrated a sensitivity of 80%, specificity 
of 91%, and positive predictive value of 78% (Power et al., 1995).    
As described previously, the anti-saccade task is a brief neurological measure 
designed to ascertain the level of control that an individual has over his or her behavior.  
It requires that participants must suppress the reflexive urge to look at a visual target that 
appears suddenly in the peripheral visual field and must instead look away from the target 
in the opposite direction.  In a typical anti-saccade task, the viewer fixates his or her gaze 
on a central location, a stimulus is flashed to one side of fixation, and the task is to not 
look at the location of the cue but rather to make an anti-saccadic eye movement in the 
opposite direction from where the cue was presented.  Trials may be administered by 
machine or manually by hand, as they were in this study.  Directions for standardized 
administration of the anti-saccade task were as follows:   
Hold both hands up at patient's shoulder width and eye height, and ask patient to 
look at your nose.  Move the index finger of one hand, and instruct patient to look 
at the finger that moves, then look back to your nose.  Practice until patient is 
familiar with task. Then, instruct patient to look at the finger that is NOT moving.  
Practice until patient understands task. Perform 20 trials.  (Power et al., 1995)  
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An error is recorded when the patient looks towards the finger that is moving.  
The number of errors in 20 trials determines the total score, where less than or equal to 
three errors equals a score of four; four errors equals a score of three; five errors equals a 
score of two; six errors equals a score of one; and more than six errors equals a score of 
zero.  To summarize and clarify, lower scores on the task are associated with more errors 
and therefore greater impairment.  In the parent study, the task was administered by 
medical residents during the participants’ medical evaluation appointment.  Results were 
recorded manually as part of the HIV Dementia Scale (Power et al., 1995) in the parent 
study. However, the anti-saccade results were not previously examined or considered as 
an independent score.  For the present study, two anti-saccade scores were recorded and 
examined: the task score as described above and the raw number of errors. 
Neuropsychological measures.  Seven domains of neuropsychological 
functioning were examined as part of the larger study from which the present archival 
data set was obtained, as recommended by the guidelines established by the NIH for the 
assessment of an HIV+ population.  The domains were attention, speed of information 
processing, episodic memory, executive functioning/abstraction, language skills, 
visuospatial skills, and motor functioning.  Within each of these domains, certain 
measures were selected by the researcher (under advisement of a co-researcher on the 
parent study) as representative of performance in that domain.  The two measures 
selected to represent attentional capabilities were the Variable Interval Reaction Time 
(VIT) Test and WAIS-R Digit Span.  The VIT Test is a simple visual reaction time task 
in which the interval between the warning signal and the imperative signal (a color block) 
varies among 25, 250, 500, 750, and 1000 milliseconds (Wilkie et al., 2004).  The Digit 
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Span subtest of the WAIS-R requires individuals to repeat a chain of verbally presented 
numbers initially forwards, then backwards (Wechsler, 1981).  
For speed of information processing, three measures were considered: the average 
decision time of the Go-No Go Paradigm, the Posner Letter Matching task, and the 
Figural Visual Scanning and Discrimination test.   The Go-No Go Paradigm is a 
computer-based task with three conditions: (a) simple reaction time requiring recognition 
of a red block on the screen, (b) simple reaction time requiring recognition of a blue 
block on the screen, and (c) a reversal condition in which the individual is to ignore the 
red and respond only to the blue signal (Wilkie et al., 2004).  The Posner Letter Matching 
task is used to measure the speed of accessing overlearned information (letters of the 
alphabet) from long-term memory by presented paired letters in a computer-based task to 
assess central processing speed relatively independent of motor speed (Wilkie et al., 
2004).  The Figural Visual Scanning and Discrimination test (Elkstrom, French, Harman, 
& Dermen, 1987) is a timed, 20 trial paper-and-pencil task requiring the participant to 
scan and discriminate between four figures to determine which is a match for the 
prototype with total time elapsed being the variable of interest.   
Two measures were selected to represent episodic memory: the California Verbal 
Learning Test (total score and free delay recall) and WMS-R Logical Memory delayed 
score.  The California Verbal Learning Test (Delis, Kramer, Kaplan, & Ober, 1987) is a 
list learning exercise with multiple cued and free recall tasks at both immediate and 
delayed time frames designed to assess verbal memory.  The Logical Memory subtest of 
the WMS-R (Wechsler, 1981) queries individuals on immediate and 30-minute delayed 
recall of short stories.    
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For executive functioning/abstraction, timed performance of Trail Making Test 
Part B, Wisconsin Card Sorting Test perseverative errors, and interference score on the 
Stroop Task were utilized.  Part B of the Trail Making Test consists of 25 circles 
distributed over a sheet of paper including numbers 1 – 13 and letters A – L (Lezak, 
Howieson, & Loring, 2004).  The patient draws lines to connect the circles in an 
ascending pattern, alternating between the numbers and letters (i.e., 1-A-2-B-3-C, etc.) as 
quickly as possible without lifting the pen or pencil from the paper.  The Wisconsin Card 
Sorting Test consists of four key cards and 128 response cards with geometric figures that 
vary according to three perceptual dimensions (color, form, or number). The task requires 
individuals to determine the correct classification principle using trial and error and 
examiner feedback (Heaton, Chelune, Talley, Kay & Curtis, 1993).  The Stroop Color 
and Word Test consists of a word page with color words printed in black ink, a color 
page with ‘Xs’ printed in color, and a color-word page with words from the first page 
printed in colors from the second page (Golden & Freshwater, 2002). The respondent 
reads words or names the ink colors as instructed as quickly as possible within a time 
limit, providing three scores based on the number of items completed on each of the three 
stimulus sheets.    
To assess language skills, the Boston Naming Test total score was used as well as 
the total scores on both the Controlled Oral Word Association Test and Category Fluency 
Task.  The Boston Naming Test is a 60-item confrontation naming test of pictures 
ordered from easiest to most difficult that measures word retrieval performance (Strauss, 
Sherman, & Spreen, 2006).  The Controlled Oral Word Association Test is a timed 
phonetic spontaneous list generating exercise in which individuals name common 
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everyday words beginning with the letters F, A, and S (Ruff, Light, Parker, & Levin, 
1996).  The Category Fluency Task (Spreen & Strauss, 1998) is a timed semantic list 
generating exercise in which individuals name as many animals as they can 
spontaneously.     
Visuospatial skills were measured by timed performance on WAIS-R Digit 
Symbol and total score on WAIS-R Block Design.  The Digit Symbol subtest of the 
WAIS-R (Wechsler, 1981) requires that the test taker writes down the corresponding 
symbol for a chart of numbers according to a provided key of digit-symbol pairs as fast as 
possible.  The Block Design subtest of the WAIS-R (Wechsler, 1981) is a timed task that 
requires an individual to use blocks marked with white sides, red sides, and red/white 
sides to copy a specified pattern demonstrated by a prototype.   
Finally, for motor functioning, timed performance on two measures was utilized: 
the WAIS-R Digit Symbol subtest and non-dominant hand performance on the Grooved 
Pegboard.  As described above, the Digit Symbol subtest of the WAIS-R (Wechsler, 
1981) requires that the test taker writes down the corresponding symbol for a chart of 
numbers according to a provided key of digit-symbol pairs as fast as possible.  The 
Grooved Pegboard task is a manipulative dexterity assessment that tests fine motor skills 
in a timed manner. (Strauss et al., 2006). 
Levels of cognitive impairment were assessed by determining if the participant’s 
performance on these neuropsychological measures was more than one or two standard 
deviations below the mean scores in each of the seven domains.  Criteria for impairment 
were consistent with Antinori et al. (2007), which defines impairment in 
neuropsychological testing performance in MND by a score of at least one standard 
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deviation below demographically-corrected norms on neuropsychological tests in at least 
two different cognitive domains, and in HAD by a score of at least two standard 
deviations below demographically corrected normative means in at least two different 
cognitive domains.  Demographically-corrected normative data for neuropsychological 
tests were primarily sourced from scoring manuals and peer-reviewed published research.  
When such resources were not applicable or available, internal norms derived from the 
scores of the youngest (i.e. aged 18-39) HIV- participants were utilized.  All scoring of 
neuropsychological measures had been completed by the principal investigators of the 
parent study, with z-scores made available for reference in the current research.     
Because the number of tests varied within domains, a process for determining 
impairment within domains was established as follows:  For domains in which there were 
two tests represented (i.e., attention, visuospatial skills, and motor functioning), both test 
scores had to be the requisite number of standard deviations below the mean as identified 
by Antinori et al. (2007) in order for one of the two impairment levels to be assigned.  
For domains in which there were three tests represented (i.e., speed of information 
processing, executive functioning/abstraction, and language skills), at least two of the 
three test scores had to be the requisite number of standard deviations below the mean.  
For episodic memory, the only domain in which there were four tests represented, at least 
three of the four test scores had to be the requisite number of standard deviations below 
the mean in order for an impairment category to be assigned. 
Functional measures.  The degree of functional impairment was ascertained by 
self-report of perceived cognitive dysfunction as defined by the Cognitive Difficulties 
Scale (CDS; McNair & Kahn, 1983), Patient Version. This measure requires that 
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respondents rate on a Likert scale how often, from 0 (not at all) to 4 (very often), they 
believe that they have experienced difficulty on various tasks related to attention, 
concentration, orientation, memory, praxis, language, and general daily functioning 
within the past month.   The CDS has
 
demonstrated high correlation
 
with performance on 
neuropsychological measures of memory and attention (r = 0.51) and good test-retest 
reliability (r = 0.77) (Spitznagel, Tremont, Brown, & Gunstad, 2006).  This assessment 
tool is consistent with Antinori et al.’s (2007) criteria for functional impairment, which 
defines MND as characterized by impairment that interferes at least mildly with daily 
functioning and has been observed for at least one month. HAD is characterized by 
marked difficulty in activities of daily living due to the cognitive dysfunction, and such 
impairment must be observed for at least one month.   
Analyses 
Descriptive statistics were calculated on all of the measures utilized in this study, 
as well as on the participant demographic variables.  Correlations between the anti-
saccade error rates, task scores, and other cognitive measures were calculated.  In order to 
determine if the anti-saccade task may be useful in predicting the level of cognitive 
impairment in HIV-infected individuals, the original research plan was for study 
participants to first be categorized into either MND or HAD diagnostic categories.  While 
originally it was proposed to use both neuropsychological and functional measures 
collectively to determine these categorizations, it was later determined that only 
neuropsychological scores would be used due to multiple complications with the data, 
most notably including discordant findings of impairment between the functional and 
neuropsychological measures.  Factors in and specifics of the decision to change criteria 
for diagnoses are presented in thorough detail with results and discussion of findings.  
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The two categories of impairment were to be formed a second time using only the 
performance scores (both raw errors and scaled scores) on the anti-saccade task.  
Categorized groups would then be compared using a two-by-two contingency table. If the 
diagnosis (either MND or HAD) as determined by neuropsychological/functional 
measures was consistent with the diagnosis as determined by the anti-saccade task, it 
would be recognized as a positive finding.  Conversely, if the diagnosis (either MND or 
HAD) as determined by neuropsychological/functional measures was inconsistent with 
the diagnosis as determined by the anti-saccade task, it was recognized as a negative 
finding.  Evaluation of the total numbers of positive and negative findings determined the 
usefulness of the anti-saccade task as a predictor of cognitive decline in HIV-infected 
individuals.     
Use of the receiver operating characteristic (ROC) curve, whereby true positive 
rates and false positive rates are used to create a mapped statistical curve, was employed.  
ROC graphs are a useful technique for organizing classifiers and visualizing their 
performance, and are commonly used in medical decision making (Fawcett, 2004).  
Because ROC graphs are based upon the true positive and false positive rates in which 
each dimension is a strict columnar ratio (Fawcett, 2004), it does not depend on class 
distribution, making it especially useful for this archival study in which data can no 
longer be collected. 
The sensitivity of any diagnostic test is the proportion of patients for whom the 
outcome is positive (i.e., who actually have the disorder or condition) that are correctly 
identified by the test, while the specificity is the proportion of patients for whom the 
outcome is negative (i.e., those who do not have the disorder or condition) that are 
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correctly not identified by the test (Bewick, Cheek, & Ball, 2004).  The true positive rate 
is equivalent to sensitivity and the false positive rate is equal to 1 − specificity, making 
the two-by-two contingency and ROC curve relevant tools in this statistical analysis.  In 
the case of this research, the plan was for both the sensitivity and specificity of the anti-
saccade task to be examined in order to assess its usefulness for the diagnosis of 
cognitive impairment by comparing it to established methods for determining cognitive 
impairment among HIV+ individuals.  Positive predictive value (PPV) is defined by the 
probability that there will be a positive outcome whereas the negative predictive value 
(NPV) is the probability that there will be a negative outcome (Bewick et al., 2004).  In 
the present study, a positive outcome was defined as a consistent diagnosis (i.e., both the 
neuropsychological/functional measures and the anti-saccade task would identify the 
same individuals in the same diagnostic category), and a negative outcome was defined 
as an inconsistent diagnosis.   
Results 
Changes to Methods 
 After the researcher performed the initial analyses for the present study, several 
changes to the research plan had to be made due to characteristics of the data.  Two 
neuropsychological tests in the Speed of Information Processing domain had to be 
excluded from the analyses for determining MND and HAD diagnosis: the Posner Letter 
Matching Task and the Go-No Go Paradigm.  After reviewing the data for the current 
study, it was determined that there was insufficient data present to provide a reliable 
standardized score for participants in the records for either of these tests.  To make up for 
the loss of this data, the scaled score from the WAIS-R Digit Symbol subtest was utilized 
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as a substitution.  This still allowed for two measures in the domain, which was sufficient 
to determine impairment via commonly applied standards (Antinori et al., 2007).  So as 
to not utilize Digit Symbol in three different domains, Grooved Pegboard, non-dominant 
hand, was the only test used to measure motor skills.   
One additional test was added to the domain of Episodic Memory, the delayed 
free recall score from the WMS-R Logical Memory subtest, when it was determined that 
sufficient data was present for analysis.  This allowed for a more robust measurement of 
the domain.  The Logical Memory subtest (Wechsler, 1981) requires the oral presentation 
of a narrative story to the examinee for immediate and delayed recall. 
Initially, it was planned to establish diagnosis (MND, HAD, or No Diagnosis) by 
utilizing the z-scores for participant performance on both neuropsychological and 
functional measures.  However, there was a major discrepancy between findings on 
neuropsychological measures and the self-report Cognitive Difficulties Scale (CDS) used 
to determine functional status.   The majority of HIV+ participants diagnosed with MND 
or HAD according to results of neuropsychological testing did not show commensurate 
levels of self-reported functional impairment on the CDS.  Had the original research plan 
been followed, the number of participants classified with MND or HAD on the basis of 
both neuropsychological and functional measures would have been so few as to make any 
additional analyses impossible.  Therefore it was deemed necessary to revise the criteria 
for initial diagnosis to include only neuropsychological test performance; precise details 
of this amended procedure are presented with results and discussion.   
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Demographic Characteristics of Participants 
Descriptive statistics were calculated for all 114 participants and are presented in 
Table 1.  Participants had an average of 12.94 years of education (SD = 2.54), with 73 
(64%) being male and 41 (36%) being female.  Average age was 47.03 (SD = 12.27), 
although it bears repeating that the age range of participants was restricted to 18-39 and 
50+ in the parent study, such that all persons aged 40-49 were excluded.  Ethnicities of 
participants were divided into three categories, with 61 who identified themselves as 
African American (53%), 17 as Hispanic (14%) and 36 as Caucasian (32%).  No other 
ethnic identities were reported.  Regarding handedness among participants, 106 (93%) 
were right-handed and 8 (7%) were left-handed.   
Among HIV+ participants (n = 81), there was an average of 13.01 years of 
education (SD = 2.59), with 56 (69%) being male and 25 (31%) being female.  Average 
age was 48.35 (SD = 11.68).  Ethnicities of HIV+ participants were divided into 46 who 
identified themselves as African American (57%), 11 as Hispanic (13%) and 24 as 
Caucasian (30%).  Regarding handedness among HIV+ participants, 76 (94%) were 
right-handed and 5 (6%) were left-handed. 
Among HIV- participants (n = 33), there was an average of 12.79 years of 
education (SD = 2.46), with 17 (52%) being male and 16 (48%) being female.  Average 
age was 43.76 (SD = 13.21).  Ethnicities of HIV- participants were divided into 15 who 
identified themselves as African American (45%), 6 as Hispanic (18%) and 12 as 
Caucasian (36%).  Regarding handedness among HIV+ participants, 30 (91%) were 
right-handed and 3 (9%) were left-handed.   
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Diagnostic Findings Utilizing Neuropsychological and Functional Measures 
 Diagnoses of MND and HAD were to be determined by inclusion of results from 
both neuropsychological and functional measures.  Among the 81 HIV+ participants, 
there were 29 assigned to the MND diagnostic category by scoring at least one (but less 
than two) standard deviations below the mean in two or more neuropsychological 
domains.  The CDS, i.e., the self-report measure of functional impairment, assigned just 
four participants to the MND diagnostic category by a score of at least one (but less than 
two) standard deviations below the mean score on the measure.  If, as originally planned, 
participants had been diagnosed with MND according to a combination of 
neuropsychological and functional measures, only two participants would have met 
diagnostic criteria for MND on both measures.  Three participants were assigned a HAD 
diagnosis based on neuropsychological test performance (scores two or more standard 
deviations below the mean in two or more domains), while six were identified as HAD 
based on CDS score (two or more standard deviations beyond the mean score on the 
measure).  Of these, only one participant would have met diagnostic criteria for HAD on 
both measures.  Therefore, in order to provide some potentially useful analyses with the 
present data, it was decided by the researcher, with advisement from the co-principal 
investigator of the parent study, to classify patients with MND or HAD using 
neuropsychological measures only.  Using this revised criteria, a total of 29 participants 
were assigned a diagnosis of MND and three participants were assigned a diagnosis of 
HAD.  Collectively, 32 of the 81 HIV+ participants (39.5%) were assigned with some 
degree of HIV-associated neurocognitive disorders (HAND).     
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Anti-Saccade Task Performance 
 In order to address the first research question regarding how HIV+ individuals 
perform on the anti-saccade task, error rates and task scores were calculated and are 
presented in Tables 2 and 3.  Among the 81 HIV+ participants, 41 participants produced 
zero errors on the anti-saccade task; six participants produced one error; 18 participants 
produced two errors; eight participants produced three errors, five participants produced 
four errors, two participants produced five errors, and one participant produced six errors.  
No participants produced greater than six errors on the task.  When using these errors 
rates to calculate anti-saccade task scores according to the instructions on the HIV 
Dementia Scale, 73 participants (90%) received a score of four, the maximum score 
possible on the task; five participants received a score of three; two participants received 
a score of two; and one participant received a score of one.  Overall, HIV+ participants 
demonstrated very good performance on the anti-saccade task, with fewer errors than 
might have been expected, and as a result, higher task scores.   
 Among the 29 HIV+ participants who were assigned a diagnosis of MND 
according to their performance on neuropsychological measures, 14 participants 
produced no errors; three participants produced one error; five participants produced two 
errors, three participants produced three errors, one participant produced four errors, two 
participants produced five errors, and one participant produced six errors.  When using 
these errors rates to calculate an anti-saccade task score according to the instructions on 
the HIV Dementia Scale, 25 participants (86%) received a maximum score of four; one 
participant (3.45%) received a score of three; two participants (7%) received a score of 
two; and one participant (3.45%) received a score of one.  As these scores indicate, the 
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vast majority of HIV+ participants diagnosed with MND performed quite well on the 
anti-saccade task.    
Among the three HIV+ participants who were assigned a diagnosis of HAD 
according to their performance on neuropsychological measures, one participant 
produced zero errors and two participants produced four errors.  When using these errors 
rates to calculate an anti-saccade task score according to the instructions on the HIV 
Dementia Scale, one participant (33.34%) received a maximum score of four and two of 
these participants (66.67%) received a score of three. 
When comparing anti-saccade task performance among HIV+ participants and 
those diagnosed with MND or HAD, care must be taken in interpretations due to the 
discrepancy in sample size.  However, with that in mind, it is interesting to note that the 
mean number of errors among HAD diagnosed participants (2.67, n = 3) was greater than 
that obtained by MND diagnosed participants (1.45, n = 29), or than that obtained by the 
entire sample of HIV+ participants (1.26, n = 81).  When these error figures are used to 
calculate task scores, the differences were less distinct among HAD diagnosed 
participants, MND diagnosed participants, and total HIV+ participants with mean scores 
of 3.34 (SD = 0.58), 3.72 (SD = 0.75), and 3.85 (SD = 0.50), respectively. Once again, the 
relatively high average task scores reflected good anti-saccade performance across 
groups.    
Association between Anti-saccade Task Performance and Diagnoses of MND and 
HAD 
A second research question sought to determine how performance on the anti-saccade 
task related to cognitive impairment and diagnoses of MND and HAD among HIV+ men 
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and women. Given that 26 of 32 (81%) HIV+ persons with diagnoses of MND or HAD 
obtained maximum scores of 4 on the anti-saccade task, overall it appeared that a HAND 
diagnosis was not associated with impaired performance on the anti-saccade task for most 
of these HIV+ participants. It was hypothesized that deficits in anti-saccade performance 
would be associated with a diagnosis of HAD among HIV+ individuals.  However, since 
only three HIV+ participants were diagnosed with HAD, and of these, none demonstrated 
a large number of errors on the anti-saccade task, there were insurmountable challenges 
in attempting to test this hypothesis. Nevertheless, to further assess the relationship 
between anti-saccade task performance and diagnoses of MND and HAD among HIV+ 
participants, sensitivity and specificity values were calculated between performance on 
the anti-saccade task (error rate and task score) and diagnosis via neuropsychological 
measures.   While the findings related to sensitivity and specificity are reported in full 
below, it is worth noting in advance that the small number of participants achieving anti-
saccade scores suggestive of impairment, along with an uneven distribution of scores, 
made rendered these analyses both insignificant and of questionable value.  As a result, 
the planned two-by-two contingency table, whereby HAND diagnoses based on 
neuropsychological test performance and functional status self report would have been 
compared with HAND diagnoses based on anti-saccade task performance, could not be 
executed due to the absence of useful cutoff scores that would have been provided by 
usable sensitivity and specificity findings.  Regardless, the data related to sensitivity and 
specificity is reported below.   
Sensitivity of Anti-saccade Task.  The sensitivity of the anti-saccade task 
represents the proportion of HIV+ participants who have been classified as having MND 
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and HAD due to impaired performance on neuropsychological measures that are also 
identified as having MND and HAD due to impaired performance on the anti-saccade 
task. This would be considered a positive outcome, in that the findings would be 
congruent.  In order to assess the sensitivity of the anti-saccade task, diagnoses of MND 
and HAD (both independently and collectively) were compared with error rates and task 
scores on the anti-saccade task.   As stated previously, the small number of participants 
achieving anti-saccade scores suggestive of impairment and uneven distribution of scores 
made these analyses largely insignificant.  Nonetheless, detailed findings for each 
analysis are presented below. 
When compared with MND diagnosis among HIV+ participants (n = 29), 
sensitivity values for error rates on the anti-saccade task were as follows: zero errors (n = 
14) on the task had a sensitivity of .483; one error (n = 3) had a sensitivity of .586; two 
errors (n = 5) had a sensitivity of .759; three errors (n = 3) had a sensitivity of .862; four 
errors (n = 1) had a sensitivity of .897; five errors (n = 2) had a sensitivity of .966, and six 
errors (n = 1) had a sensitivity of 1.000.   
When compared with MND diagnosis among HIV+ participants (n = 29), 
sensitivity values for task score on the anti-saccade task were as follows: a score of four 
(n = 25) on the task had a sensitivity of 1.000; a score of three (n = 1) on the task had a 
sensitivity of .138; a score of two (n = 2) on the task had a sensitivity of .103; and a score 
of one (n = 1) on the task had a sensitivity of .034. 
When compared with HAD diagnosis among HIV+ participants (n = 3), 
sensitivity values for error rates on the anti-saccade task were as follows: zero errors (n = 
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1) on the task had a sensitivity of .333 and four errors (n = 2) had a sensitivity of 1.000.  
No other rates of errors were recorded among the three participants.   
When compared with HAD diagnosis among HIV+ participants (n = 3), 
sensitivity values for task score on the anti-saccade task were as follows: a score of four 
(n = 1) on the task had a sensitivity of 1.000 and a score of three (n = 2) on the task had a 
sensitivity of .667.  No other task scores were recorded among the three participants.   
When considering MND and HAD diagnoses jointly to reflect a general diagnosis 
of some degree of HAND among HIV+ participants (n = 32), sensitivity values for error 
rates on the anti-saccade task were as follows: zero errors (n = 15) on the task had a 
sensitivity of .531; one error (n = 3) had a sensitivity of .438; two errors (n = 5) had a 
sensitivity of .281; three errors (n = 3)  had a sensitivity of .188; four errors (n = 3) had a 
sensitivity of .094; five errors (n = 2) had a sensitivity of .031, and six errors (n = 1) had a 
sensitivity of zero.   
When compared with diagnosis of some degree of HAND among HIV+ 
participants (n = 32), sensitivity values for task score on the anti-saccade task were as 
follows: a score of four (n = 26) on the task had a sensitivity of zero; a score of three (n = 
3) on the task had a sensitivity of .813; a score of two (n = 2) on the task had a sensitivity 
of .906; and a score of one (n = 1) on the task had a sensitivity of .969. 
Specificity of Anti-saccade Task.  The specificity of the anti-saccade task 
represents the proportion of HIV+ participants who have been classified as not having 
MND or HAD on the basis of their performance on neuropsychological measures that are 
also classified as not having MND or HAD on the basis of their performance on the anti-
saccade task. This would be considered a desirable outcome in that the findings would be 
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congruent in showing the absence of significant impairment by both methods.  In order to 
assess the specificity of the anti-saccade task, diagnoses of MND and HAD (both 
independently and collectively) were compared with error rates and task scores on the 
anti-saccade task.   To briefly summarize the findings related to specificity, it appears that 
while fewer  numbers of errors and corresponding higher scores on the task were 
associated with no diagnosis of MND and HAD in select cases, the small number of 
participants achieving anti-saccade scores suggestive of impairment and the uneven 
distribution of scores made these analyses largely insignificant and of little value.  
Detailed values for each analysis are presented below. 
When compared with MND diagnosis among HIV+ participants (n = 29), 
specificity values for error rates on the anti-saccade task were as follows: zero errors (n = 
14) on the task had a specificity of .481; one error (n = 3) had a specificity of .423; two 
errors (n = 5) had a specificity of .173; three errors (n = 3) had a specificity of .077; and 
four or more errors (n = 4) had a specificity of zero. 
When compared with MND diagnosis among HIV+ participants (n = 29), 
specificity values for task score on the anti-saccade task were as follows: a score of four 
(n = 25) on the task had a specificity of zero; a score of three (n = 1) on the task had a 
specificity of .923; while a score of one or two on the task (n = 3) each had a specificity 
of 1.00. 
When compared with HAD diagnosis among HIV+ participants (N = 3), 
specificity values for error rates on the anti-saccade task were as follows: zero errors (n = 
1) on the task had a specificity of .487 and four errors (n = 2) had a specificity of .038.   
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When compared with HAD diagnosis among HIV+ participants (N = 3), 
specificity values for task score on the anti-saccade task were as follows: a score of four 
(n = 1) on the task had a specificity of zero and a score of three (n = 2) on the task had a 
specificity of .023. 
When considering MND and HAD diagnoses jointly to reflect a general diagnosis 
of some degree of HAND among HIV+ participants (N = 32), specificity values for error 
rates on the anti-saccade task were as follows: zero errors on the task had a specificity of 
.531; one error had a specificity of .592; two errors had a specificity of .857; three errors 
had a specificity of .959; and four or more errors had a specificity of 1.000. 
When compared with diagnosis of some degree of HAND among HIV+ 
participants (N = 32), specificity values for task score on the anti-saccade task were as 
follows: a score of four on the task had a specificity of 1.000; a score of three on the task 
had a specificity of .041; while a score of one or two on the task each had a specificity of 
zero. 
Association between Anti-saccade Task and Performance on Other Cognitive 
Measures  
It was hypothesized that severe deficits in anti-saccade task performance would 
be associated with performance deficits on other measures of cognitive functioning 
among HIV+ individuals (see Tables 4 and 5 for summary information regarding 
performance on cognitive measures across groups).  Because so few HIV+ participants 
showed significant deficits in anti-saccade performance, this hypothesis could not be 
adequately tested.  To examine for the presence of any significant relationships that 
would be generally consistent with this hypothesis, Pearson correlation coefficients were 
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calculated between the anti-saccade error rates and task scores and neuropsychological 
test performance among HIV+ persons.  It was found that only one neuropsychological 
test, Digit Symbol, had a significant relationship to both anti-saccade error rates, r (79) = 
-.254, p = .022, and task score r (79) = .274, p = .013.  As would be expected given the 
hypothesis, greater deficits in anti-saccade task performance (i.e., more errors, resulting 
in a lower task score) were associated with poorer performance on Digit Symbol.  An 
unanticipated finding was discovered in that Grooved Pegboard, non-dominant hand, had 
a significant relationship to the anti-saccade task score, r (79) = .237, p = .034, meaning 
that as time to complete Grooved Pegboard increased (signifying poorer performance), 
anti-saccade task score also increased.  None of the other correlations between anti-
saccade errors or task scores and neuropsychological measures were statistically 
significant among the HIV+ participants.  These findings are reported in Table 6. 
Additional Analyses 
To further explore any potential association between the anti-saccade task and 
other cognitive measures, Pearson correlation coefficients were calculated between anti-
saccade task scores and error rates and scores on neuropsychological measures among all 
participants (N = 114).  These findings are presented in Table 6.  The purpose of this 
analysis was to determine if performance on the anti-saccade task would be associated 
with impairment on neuropsychological measures in this community sample, regardless 
of HIV status.  In this larger group, statistically significant correlations were found 
between Digit Symbol and both anti-saccade error rates, r (112) = -.235, p = .012, and 
task scores, r (112) = .241, p = .010.  This was consistent with the researcher’s 
expectations in that poorer performance on the anti-saccade was in fact associated with 
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lower scores on Digit Symbol.  Once again, the unexpected finding of a statistically 
significant relationship between poorer performance on Grooved Pegboard, non-
dominant hand, and higher scores on the anti-saccade task score was found, at r (112) 
=.237, p = .011.   No other correlations, either in terms of error rates or task scores, were 
found to be statistically significant.   
 In order to better explore the finding that only ten of 81 HIV+ participants showed 
self-reported functional impairment on the CDS (four at the level associated with MND 
and six at the level representing HAD), some additional exploratory analyses were 
conducted.  Given that participants were either younger than 40 or older than 49 as per 
the design of the parent study, the relationship of age to CDS was considered.  The 
younger participants (n = 27) showed a mean CDS score of 38.30 (SD = 33.70), while the 
older participants (n = 54) obtained a mean CDS of 38.46 (SD = 19.33).  While the mean 
scores were similar, a broader variance of self-reported scores among younger HIV+ 
individuals was noted.  A correlation was also calculated between age and CDS for the 
entire HIV+ sample (n = 81) and it showed a positive but negligible association, r (79) = 
.086, p > .05.    
Discussion 
 This exploratory research study sought to investigate the performance of HIV+ 
participants on the anti-saccade task, and how this performance might relate to cognitive 
functioning and diagnoses of MND and HAD.  This exact relationship had not previously 
been examined in published literature.   As one might expect with archival research, 
complications secondary to the archival data set provided some challenges and 
necessitated some changes in the methodology.  Nonetheless, this exploratory research 
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provided some insight into the value of the anti-saccade task as a diagnostic tool, both in 
positive and negative findings.  
Research Questions and Hypotheses  
 In terms of the original two research questions, (a) how HIV+ individuals perform 
on the anti-saccade task and (b) how performance on the anti-saccade task relates to 
cognitive impairment and diagnoses of MND and HAD among HIV+ men and women, 
some challenges arose due to the exploratory nature of this archival research.  
Performance on the anti-saccade task was manually recorded from filed records and 
analyzed by this writer and was not a specific focus of the parent study.  After the anti-
saccade data were analyzed for the present study, it appeared that variability and 
distribution of both error rates and anti-saccade task scores were severely limited with 
greater than half (50.6%) of HIV+ participants scoring zero errors on the measure (see 
Table 2), and more than nine out of ten (90.1%) achieving a score of 4 (see Table 3), the 
highest attainable on the task.  No HIV+ participant scored more than 6 errors (out of 20 
trials total), and only three (of 81) scored greater than 4 errors.  Additionally, the medical 
and cognitive condition of the sample was unknown prior to the commencement of data 
analysis, and turned out to be better than expected overall based upon both participants’ 
self-report of functional status and performance on the anti-saccade task.  This was, in 
essence, a relatively healthy, well-functioning group based on those measures.   
It was necessary to develop a method for classifying levels of HIV-associated 
neurocognitive disorders (HAND) after the data had been collected and coded.  Informed 
by clinical and research guidelines (Antinori, 2007), diagnosis of MND was originally to 
be defined by (a) performance at least one, but less than two standard deviations beyond 
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the mean in at least two neuropsychological domains and (b) mild to moderate functional 
impairment, while HAD was to be defined by (a) performance at least two standard 
deviations beyond the mean in at least two neuropsychological domains and (b) 
significant functional impairment.  However, once the scores on the Cognitive 
Difficulties Scale (CDS) were compared with neuropsychological test performance, the 
results were found to be largely incongruent.  In general, participants in the parent study 
did not report a great deal of functional problems in their daily lives, as per the CDS.  
Specifically, there were 29 HIV+ participants who scored one SD beyond the mean on 
neuropsychological testing, while only four responded to a sufficient number of self-
report items to indicate functional impairment on the CDS.  Comparing these two 
outcomes, only two HIV+ participants would have reached criteria for MND taking into 
account both neuropsychological testing and the functional measure.  Therefore, it was 
decided by the principal investigator (under advisement from a co-investigator of the 
parent study) to assign diagnoses of MND or HAD based on neuropsychological testing 
scores only.  Using this approach, 29 HIV+ participants were assigned a diagnosis of 
MND and three participants met the criterion for HAD, for a total of 32 HAND diagnoses 
of the 81 participants (39.5%).  However, given the lack of self-reported functional 
impairment among these participants, their assignment to categories of MND or HAD 
must be viewed as provisional at best.  
In addition to the difficulties described above, determination of how performance 
on the anti-saccade task related to diagnoses of MND and HAD was somewhat thwarted 
by the participants’ relatively good performance on the anti-saccade task itself.  The most 
critical step in determining the predictive value of the anti-saccade task would have been 
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to compare HAND diagnosis using the anti-saccade task to HAND diagnosis using 
traditional means.  This approach would require the creation of a cut-off point for 
diagnostic categories from continuous data, i.e., anti-saccade error rates and task scores in 
this study.  These values are not intrinsic to the ROC analysis but are critically dependent 
upon the clinical context (Florkowski, 2008).  The lack of variance and the generally 
good performance by HIV+ persons on the anti-saccade task made it impossible to 
determine clinically relevant cutoff scores for MND or HAD diagnosis using the anti-
saccade task.  An unanticipated finding of this research was that so many of the HIV+ 
persons in this sample performed within normal limits on the anti-saccade task.  Because 
so many of the HIV+ participants performed well, there was diminished value in 
comparing diagnosis of HAND based on the anti-saccade task to traditional means of 
diagnosis.  It appears that the anti-saccade task was not useful as an indicator of cognitive 
decline and HAND diagnoses among the participants represented in this specific data set. 
These circumstances therefore made it difficult to address the study’s hypotheses. 
A possible explanation of better-than-anticipated performance on the CDS as well 
the anti-saccade task is that the parent study sample seemed to be comprised of relatively 
healthy, well-functioning HIV+ individuals.  As previously discussed in the literature 
review, the advent of HAART regimes has greatly improved the prognosis for HIV 
infection, and it appears that these participants were not experiencing a great deal of 
HIV-related cognitive or functional decline in their lives, perhaps due to these improved 
medical treatments, or potentially other unidentified factors.  
It was also hypothesized that severe deficits in anti-saccade task performance 
would be associated with performance deficits on other measures of cognitive 
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functioning.  Once again, the absence of any significant number of HIV+ persons with 
severe deficits in anti-saccade task performance made it difficult to address this 
hypothesis.  Although the hypothesis could be said to have been unsupported by the lack 
of severe deficits in anti-saccade task performance, a series of correlations was calculated 
on an exploratory basis to determine what neuropsychological tests and domains would 
correlate with performance on the anti-saccade task.  Among the HIV+ participants, 
performance on the anti-saccade task was significantly correlated with performance on 
Digit Symbol, which was represented in both the speed of information processing domain 
and the visuospatial domain, showing a significant relationship with performance on both 
the error rate (-.254) and task score (.274). These findings were consistent with the 
researcher’s expectation that poorer performance on the anti-saccade would be associated 
with poorer performance on other neuropsychological measures among HIV+ 
individuals.  Conversely, Grooved Pegboard, non-dominant hand, also had a significant 
relationship to anti-saccade task score (.237), but in the unexpected direction.  Poorer 
performance on Grooved Pegboard, non-dominant hand, as reflected by greater time to 
complete the task, was associated with greater scores on the anti-saccade task, which 
represents better performance.  Even though the correlation was modest, this finding was 
inconsistent with the researcher’s general expectations for the data.  Certainly more 
research is needed on the relationship of the anti-saccade task scores to Grooved 
Pegboard, non-dominant hand, before any conclusions can be drawing about the meaning 
of the association.  None of the other correlations were statistically significant among the 
HIV+ participants, suggesting little overall association between the anti-saccade task and 
the other cognitive measures utilized in the study.   
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When looking at correlations between the anti-saccade task and other cognitive 
measures for the entire sample (see Table 6), a similar pattern was found as had been 
displayed among HIV+ individuals: Digit Symbol was significantly associated with both 
the anti-saccade error rate (-.235) and task score (.241).  These results were consistent 
with the researcher’s expectations.  Once again, there was also the unexpected positive 
relationship between performance on the Grooved Pegboard, non-dominant hand, and the 
anti-saccade task score (.237).  As noted earlier, more research is needed to confirm this 
unexpected association before any conclusions can be drawn.  It is important to mention 
that because numerous correlations were calculated in the exploratory analyses, the 
possibility of obtaining significant associations simply by chance must be considered.  
Any significant findings obtained should therefore be viewed only as suggestive and as 
areas to be explored in future research. 
Limitations of the Study 
 Over the lengthy period of data collection in the longitudinal parent study, there 
have been changes to standards of care as the body of knowledge related to HIV has 
expanded.  Specifically, diagnostic criteria and nomenclature for degrees of HIV-
associated cognitive decline have been updated from AAN’s 1991 standards to HNRC’s 
2007 standards.  At the commencement of the current research, the data for the parent 
study had not been coded to reflect these changes, and as a result, decisions regarding 
appropriate diagnoses were made using informed clinical judgment.   However, it is 
essential to note that without access to the participants or consultation with appropriately 
trained physicians, the diagnoses as determined can be considered no more than 
estimations of the participants’ actual cognitive states. An additional limitation of this 
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research study is that the usefulness of the anti-saccade task was to be determined by 
comparison to neuropsychological and functional measures, and while these measures are 
considered fractional elements of the “gold standard” of diagnostic determination by 
current standards (McArthur et al., 2007), they do not provide absolute certainty in terms 
of diagnosis. Furthermore, due to unexpected findings within the data set, use of 
functional data was eliminated entirely when HAND-related diagnostic groups were 
created.  Instead, the researcher had to rely solely on neuropsychological test 
performance, representing an even more narrow set of criteria and raising questions about 
whether diagnoses of MND and HAD were truly warranted.  These limitations made it 
difficult to fully address the objectives of the present study.  
The fact that functional impairment was determined solely through participant 
self-report in the present study represented another limitation.  In an ideal design, the 
input of clinicians and collaterals would have been considered in determining levels of 
functional impairment. Doing so may have increased the likelihood that reliable data on 
levels of daily functioning would have been found.  Alternatively, it is entirely possible 
that this sample represented a relatively healthy, well-functioning group where little 
functional impairment would have been found regardless of method.   As it was not a 
focus of this study, it is unknown precisely what factors affected the functional status of 
these participants.    
The archival nature of the current research also provides several limitations worth 
noting.  While standardized test administration procedures were described in detail and 
adherence to these standards was documented in detail, no doubt some inconsistencies 
were present in the findings due to the nature of human error, especially among 
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individual administrations of the anti-saccade task, the measure of primary interest in this 
research. The researcher did not have the ability to independently determine the 
reliability of anti-saccade task administration or scoring.  Further, many of the 
neuropsychological tests examined in this study have been updated to more recent 
editions in current clinical and research practice, but remained unchanged in the parent 
study to uphold consistency so there would be comparability between earlier and later 
participants.  As was described in the Results chapter, the WAIS-R Digit Symbol subtest 
ended up being used to represent two different neuropsychological domains: speed of 
information processing and visuospatial skills.  A research design that would have 
included less redundancy of measurement across these domains might have yielded 
additional information.   Additionally, the domain of motor functioning was represented 
by only one test, Grooved Pegboard, non-dominant hand.  Preferably, more than one test 
would be used to represent functioning in motor skills, and doing so may have provided 
supplementary information.  Having additional measures available from the motor skills 
domain would have been especially valuable considering the unexpected positive 
relationship found between anti-saccade task scores and Grooved Pegboard, non-
dominant hand performance.   
Regarding the exclusionary criteria for participation, potential participants with 
advanced HAD were screened out of the parent study, due to concerns about their ability 
to complete the battery of neuropsychological measures.  This was unfortunate as 
performance on the anti-saccade task by persons with HAD would have been most 
relevant to the current research study.  Given the longitudinal design of the parent study, 
it is understandable why this exclusionary criterion was put into place, however, since the 
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present study examined only the first visit from each participant, access to anti-saccade 
and neuropsychological test performance on such participants would have been extremely 
valuable.       
In summary, there were multiple limitations that were discovered during the 
analysis phase of the research, with some of the measures being quite challenging in 
terms of planned analysis due to an unexpected lack of variance.  Specifically, the 
method by which diagnoses were to be determined, both by 
neuropsychological/functional means and by the anti-saccade measure, could not be fully 
accomplished when taking into account participant data.  As a result, the predictive value 
of the anti-saccade task in terms of MND or HAD diagnosis was impossible to ascertain 
for this group of participants.  Multiple potential reasons for this outcome exist, including 
the possibility that many of the HIV+ participants in the study were relatively healthy and 
free of the types of cognitive problems that the anti-saccade task is designed to assess.  It 
is also possible that human error in the administration or scoring of the anti-saccade task 
led to inaccurate assessments.  Because the anti-saccade task was administered by hand 
and by multiple individuals, the measure itself was not standardized beyond the general 
directions provided as instructions.  If the study had included a greater number of 
participants diagnosed with any degree of HAND, and especially HAD, the study’s 
hypotheses could have been more fully examined.  Ultimately, if valid and reliable 
diagnoses of HAND existed at the origination of the parent study, and those participants 
had been diagnosed in real time by physicians consulting on their cases, it may have 
potentially been more reasonable to compare performance on the anti-saccade task with 
those firm diagnoses, assuming of course that a greater number of diagnoses would have 
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been given.  With the present data set, and including measures such as the anti-saccade 
task and the self-report measure of functional impairment, it proved to be challenging to 
identify sub-groups of participants that could be reasonably and meaningfully compared 
on the dimensions of interest.   
As with any sample-based research study, and particularly in a study with a 
relatively small N, the findings may not generalize well to the broader HIV+ population. 
The parent study also excluded HIV+ individuals who were between the ages of 40 and 
49, which further limits generalizability.  However, this study may produce some 
findings that will be useful to researchers as well as to health professionals engaged in 
diagnosing and treating HIV-associated cognitive decline.   
Implications of Results and Directions for Future Research 
The current research was successful in demonstrating anti-saccade performance 
among HIV+ individuals in a community sample. Overall, low error rates were common 
and task performance was generally better than might have been expected.  As a result, 
the second research question proved much more difficult to address. In fact, the findings 
were inconclusive overall in terms of the usefulness of the anti-saccade task as a 
screening measure for MND or HAD.  The lack of findings within the current research 
does not preclude the possibility that the anti-saccade task may be of use in diagnosing 
HAND when administered and studied in a standardized, regulated manner, and when 
used among HIV+ patients who show more variance on the anti-saccade task.  Additional 
research with perhaps less stringent exclusionary criteria in which HIV+ participants are 
diagnosed by neuropsychological testing, more comprehensive functional assessment 
(including both clinical and collateral ratings in addition to self report) and full medical 
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workup may provide more information about the usefulness of the anti-saccade task in 
diagnosing MND and HAD.  Standardized administration of the anti-saccade task, 
perhaps administration by computerized means in lieu of hand administration, may also 
be a truer test of the measure.  Significant correlations between performance on the anti-
saccade task and Digit Symbol were intriguing and warrant further attention in future 
research.  For the present study, Digit Symbol was used to represent the 
neuropsychological domains of visuospatial functioning and speed of information 
processing.  The significant association with the anti-saccade suggests that the task may 
be useful as a screener for general neuropsychological decline, and further examination 
of the task may provide useful information.   
The incongruence between the Cognitive Difficulties Scale and overall 
neuropsychological testing performance was an additional highlight of this research.  
While this was not a focus of study but rather an incidental finding, it remains an 
intriguing discovery that this self-report measure, often used as a screening measure to 
detect potential deficits in cognitive and motor skills, was largely not congruent with 
neuropsychological test performance.  More research is needed on the relationship of 
self-reported functional assessment to cognitive and neuropsychological test performance 
among HIV+ persons.  The findings of the present study suggest the need to incorporate 
multiple measures of functioning, rather than relying solely upon self report.   
Conclusion 
 In spite of the many complications and setbacks, it is the researcher’s opinion that 
the time and effort put towards this research was constructive overall.  The study 
succeeded in providing information about how an ethnically diverse sample of HIV+ 
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individuals performed on the anti-saccade task, and a number of intriguing correlations 
between the anti-saccade task and other cognitive measures were identified. Certainly 
more research is needed to identify methods that will be useful in identifying and better 
understanding the cognitive challenges associated with HIV infection.  
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Table 1 
 
 
  
Demographic Characteristics of Participants   
 Total (N = 114) HIV+ (n = 81) HIV- (n = 33) 
 N % n % n % 
Age       
     18 - 39 44 39 27 33 17 52 
     50+ 70 61 54 67 16 48 
     Mean 47.03  48.35  43.76  
     SD 12.27  11.68  13.21  
Gender       
     Male 73 64 56 69 17 52 
     Female 41 36 25 31 16 48 
Ethnicity       
     African American 61 54 46 57 15 45 
     Hispanic 17 15 11 14 6 18 
     Caucasian 36 32 24 30 12 36 
Education       
     Mean 12.94  13.01  12.79  
     SD 2.54  2.59  2.46  
Handedness       
     Right 106 93 76 94 30 91 
     Left 8 7 5 6 3 9 
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Table 2 
 
 
  
Anti-Saccade Error Rates        
Number of Errors 0 1 2 3 4 5 6 
All participants (N = 114) 65 7 24 8 6 3 1 
HIV+ participants (n = 81) 41 6 18 8 5 2 1 
HIV+, MND diagnosed (n = 29) 14 3 5 3 1 2 1 
HIV+, HAD diagnosed (n = 3) 1 0 0 0 2 0 0 
HIV+, HAND diagnosed (n = 32) 15 3 5 3 3 2 1 
HIV- participants (n = 33) 24 1 6 0 1 1 0 
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Table 3 
Anti-Saccade Task Scores 
Score  4 3 2 1 
All participants (N = 114) 104 6 3 1 
HIV+ participants (n = 81) 73 5 2 1 
HIV+, MND diagnosed (n = 29) 25 1 2 1 
HIV+, HAD diagnosed (n = 3) 1 2 0 0 
HIV+, HAND diagnosed (n = 32) 26 3 2 1 
HIV- participants (n = 33) 31 1 1 0 
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Table 4 
 
  
Participant Performance on All  Measures, Z-Scores   
Measure 
All Participants    
(N = 114) 
HIV+                                 
(n = 81) 
HIV-                              
(n = 33) 
 Z-Score Z-Score  Z-Score  
Anti-saccade Error Rate * -0.12 0.28 
Anti-saccade Task Score * -0.04 0.09 
Cognitive Difficulties Scale * -0.13 0.31 
Digit Span  0.28 0.18 0.54 
Figural Visual Scanning Discrimination 0.73 0.91 0.31 
Digit Symbol -0.18 -0.21 -0.10 
CVLT List A Immediate Recall -0.03 0.20 -0.59 
CVLT Long Delay -0.47 -0.36 -0.76 
Logical Memory II  0.43 0.42 0.45 
Trail Making Test Part B -0.71 -0.76 -0.58 
Visual Reproduction Delay -0.37 -0.46 -0.13 
WCST Perseverative Errors -0.04 -0.10 0.11 
Stroop C -0.17 -0.25 0.03 
Boston Naming Test -1.97 -1.97 -1.97 
COWA FAS -0.73 -0.74 -0.72 
Category Fluency Animal Naming -0.92 -0.98 -0.77 
Block Design -0.15 -0.21 -0.02 
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Table 5 
Participant Performance on All  Measures, Means and Standard Deviations   
Measure All Participants      
(N = 114) 
HIV+                                 
(n = 81) 
HIV-                              
(n = 33) 
 Mean SD Mean SD Mean  SD 
Anti-saccade Error Rate 1.08 1.47 1.30 1.53 0.67 1.26 
Anti-saccade Task Score 3.86 0.47 3.85 0.50 3.91 0.38 
Cognitive Difficulties Scale 35.41 23.90 38.40 24.83 28.06 19.95 
Digit Span  10.89 3.24 10.57 3.31 11.67 2.97 
Figural Visual Scanning 
Discrimination  
69.45 25.55 71.56 28.77 64.27 14.00 
Digit Symbol 9.46 2.64 9.36 2.75 9.70 2.38 
CVLT List A Immediate 
Recall 
51.54 9.73 51.00 10.54 52.85 7.34 
CVLT Long Delay 11.04 2.99 11.06 3.25 10.97 2.27 
Logical Memory II  60.32 29.21 59.31 29.79 62.82 28.00 
Trail Making Test Part B 88.25 53.46 91.96 59.29 79.13 34.41 
Visual Reproduction Delay 38.18 26.83 35.42 25.77 45.00 28.56 
WCST Perseverative Errors 13.82 12.18 14.84 12.88 11.33 10.03 
Stroop C 133.40 58.03 135.57 66.98 128.07 25.15 
Boston Naming Test 49.06 8.43 48.91 9.01 49.42 6.91 
COWA FAS 34.98 11.25 34.88 11.97 35.24 9.39 
Category Fluency Animal 
Naming 
17.02 4.71 16.53 4.15 18.21 5.78 
Block Design 9.54 2.68 9.37 2.65 9.94 2.77 
Grooved Pegboard 94.73 26.93 96.20 28.96 91.14 21.22 
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Table 6 
Pearson Correlations Between Neuropsychological Tests and Anti-saccade Task  
 Anti-saccade Error Rate Anti-Saccade Task Score 
Measure All 
Participants         
(N = 114) 
HIV+     
(n = 
81) 
HIV-     
(n = 33) 
All 
Participants 
(N = 114) 
HIV+      
(n = 81) 
HIV-     
(n = 33) 
Digit Span  -.130 -.134 -.011 .132 .166 .157 
Figural Visual Scanning 
Discrimination 
.148 .164 -.068 -.145 -1.63 .208 
Digit Symbol -.235* -.254* -.138 .241** .274* .106 
CVLT List A Immediate 
Recall 
-.086 -.117 .069 .055 0.69 -.062 
CVLT Long Delay -.018 -.071 .051 .119 .184 -.080 
Logical Memory II  .030 .049 -.028 -.085 -.084 -.095 
Visual Reproduction -.064 -.007 -.090 .099 .105 .058 
Trail Making Test Part B -.084 -.070 -.098 .101 .063 .237 
WCST Perseverative Errors -.111 -.103 -.107 .033 .020 .059 
Stroop C -.168 -.160 -.191 .173 .160 .293 
Boston Naming Test .048 .014 .170 .057 .107 -.125 
COWA FAS -.137 -.087 -.341 .152 .121 .285 
Category Fluency Animal 
Naming 
-.166 -.187 -.072 .164 .187 .096 
Block Design -.034 .001 -.068 .112 .097 .142 
Grooved Pegboard -.180 -.185 -.187 .237* .237* .248 
* Correlation is significant at .05 level 
** Correlation is significant at .01 level 
 
